Assessing Tele-Health Outcomes in Multiyear Extensions of PD Trials

Completed

Conditions studied: Parkinson Disease

In brief

An observational study to characterize and compare long-term clinical outcomes data collected remotely through periodic tele-visits, interactive smartphone app sessions, and web-based surveys in individuals with Parkinson's Disease (PD) who have completed the interventional phases of the STEADY-PD3 and SURE-PD3 clinical trials.

Key facts

Study ID

NCT03538262

Run by

Massachusetts General Hospital

People needed

226

Starts

2018-10-01

Expected to finish

2022-03-21

Last updated by the study team

2023-06-12

Who can join

Age: any. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Enrollment in STEADY-PD3 or SURE-PD3 studies
• Prior consent to be contacted by the University of Rochester (UR) or if a participant from STEADY-PD III or SURE-PD3 studies directly contacts UR to request information about study participation
• Internet-enabled device that will support participation in tele-visits
• Have created or willing to create a Global Unique Identifier (GUID)
• Willing and able to provide informed consent
• English fluency
• For participants opting to participate in the smartphone component, possession of a suitable smartphone (iPhone or Android) with adequate data plan and cellular network access/signal or wifi access

You may not qualify if…

• Inability to carry out study activities as determined by study staff

Where it is running

• CHeT Telemedicine (Site 363) — Rochester, New York, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.